日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Inhaled vaccine shows signs of promise

By WANG XIAOYU | CHINA DAILY | Updated: 2021-07-29 09:08
Share
Share - WeChat
A worker takes a jab of COVID-19 vaccine in Nanjing, East China's Jiangsu province on June 8, 2021. [Photo/Xinhua]

A two-dose inhaled COVID-19 vaccine developed by Chinese researchers appears to be safe and capable of eliciting strong immune responses comparable to those of its one-dose injected counterpart, a preliminary study released this week said.

Cansino Biologics, which created the vaccine with the Academy of Military Medical Sciences' Beijing Institute of Biotechnology, said it is the first company in the world to publish clinical data on an aerosol COVID-19 vaccine.

Results from its early stage human trial are promising and support further research into what promises to be an effective and economical candidate, it said.

The company's injectable COVID-19 vaccine gained conditional approval from the top drug regulator in late February, and the new version is identical in terms of composition, packaging and manufacturing process, except that it is delivered through inhalation and contains a lower dosage-about one-fifth that of the injection.

The study's results were published in The Lancet Infectious Disease, based in the United Kingdom, on Monday. It recruited 130 volunteers aged 18 or older in late September. They were given five different vaccine combinations that varied in dosage and delivery method.

The results show that the inhaled vaccine, known as aerosolized Ad5-nCoV, was well tolerated, with no severe adverse reactions reported. The most common symptoms included fever, fatigue and headache.

The study said the proportion of participants reporting adverse reactions was markedly higher among those who received injections than among those in the inhalation group.

In terms of efficacy, the study said one dose of the inhaled vaccine could induce a strong immune response, and after two doses, it "could produce similar SARS-CoV-2 neutralizing antibody titers (concentrations) as one dose of intramuscular vaccination".

The study also looked into the effects of first administering an injection and then delivering the second dose through inhalation as a booster, which also triggered robust antibody responses.

"In conclusion, the aerosol inhalation of Ad5-nCoV is painless, simple, well tolerated, and immunogenic, and the current data support the evaluation of aerosolized Ad5-nCoV in ongoing phase 2 and 3 clinical trials," the study said. It added that the study was limited in that the sample size was relatively small.

No inhaled COVID-19 vaccines have been approved for use, but researchers around the world have stepped up research due to their potentially unique strengths.

Hou Lihua, a researcher at the institute, told China Central Television that the new vaccine could potentially increase the willingness of the public to get vaccinated because of the lower rates of adverse events.

The product's lower dosage could also relieve some pressure on production capacity, he said, adding that the inhalation method also obviates concerns about medical waste such as syringe needles.

Yu Xuefeng, chairman and CEO of Cansino, said in an earlier interview that in addition to humoral and cellular immune responses-protections triggered by regular injected vaccines-inhaled vaccines can induce an extra layer of protection known as mucosal immunity.

"Because the novel coronavirus usually invades human bodies through the respiratory mucosa, setting up the first defense against the virus at its inception point will generate good protective effects," he said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美精品综合 | 日本视频免费高清一本18 | 欧美激情一区二区三级高清视频 | 欧美激情欧美激情在线五月 | 久久精品成人免费国产片桃视频 | 在线播放中文字幕 | 丝袜美腿中文字幕 | 日韩视频在线精品视频免费观看 | 啪啪成人 | 午夜色视频在线观看 | 国产婷婷色一区二区三区在线 | 欧美日韩精品一区二区在线播放 | 久久涩涩 | 天天成人综合网 | 欧美成人精品不卡视频在线观看 | 亚洲国产成人在线 | 成人毛片免费网站 | 亚洲毛片网站 | 啪啪激情婷婷久久婷婷色五月 | 啪一啪在线视频 | 九九99久久精品在免费线bt | 视频一区二区三区四区五区 | 国产精品美女久久久久久免费 | 日韩女性性生生活视频 | 欧美日韩国产综合视频在线看 | 亚洲AV久久久噜噜噜久久 | 久久夏同学国产免费观看 | 三级精品在线观看 | 精品久久一区二区三区 | 亚洲精品久久久蜜桃 | 婷婷尹人香蕉久久天堂 | 极品狂兵电视剧免费观看 | 最新亚洲国产 | 亚洲在线一区二区 | 久久精品 | 色亚洲色图 | 国内精品一区二区2021在线 | 精品欧美一区二区三区免费观看 | 欧美久在线观看在线观看 | 欧美亚洲视频 | 综合精品 |